CPI-818
CPI-818-001
Phase 1 small_molecule active
Quick answer
CPI-818 for T-cell Lymphoma is a Phase 1 program (small_molecule) at Corvus Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Corvus Pharmaceuticals
- Indication
- T-cell Lymphoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active